Combined Complete Decongestive Therapy Reduces Volume and Improves Quality of Life and Functional Status in Patients With Breast Cancer-Related Lymphedema

Borman P., Yaman A., Yasrebi S., Inanli A. P. , Donmez A. A.

CLINICAL BREAST CANCER, vol.22, no.3, 2022 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 3
  • Publication Date: 2022
  • Doi Number: 10.1016/j.clbc.2021.08.005
  • Journal Indexes: Science Citation Index Expanded, Scopus, CINAHL, EMBASE, MEDLINE
  • Keywords: Breast cancer-related lymphedema, complete decongestive therapy, volume, quality of life, functional status, PNEUMATIC COMPRESSION PUMP, UPPER EXTREMITY LYMPHEDEMA, LYMPHATIC THERAPY, PROSPECTIVE TRIAL, PHYSIOTHERAPY, MASTECTOMY, DEPRESSION, DRAINAGE, EDEMA, WOMEN


The aim of this study was to evaluate the effects of complex decongestive therapy (CDT) in patients with breast cancer-related lymphedema (BCRL), in regard to volume reduction, functional status and quality-of-life (QoL). CDT in combined manner performed daily for 3 weeks, can greatly reduce the volume as well as improve the disability and impaired QoL, especially when performed earlier in patients with BCRL.